 |
Fred D. Finkelman, M.D. holds the McDonald Chair in Internal Medicine and is Director of the Division of Immunology (Rheumatology and Allergy) at the University Of Cincinnati College Of Medicine, directs the Division of Rheumatology at the Cincinnati Veterans Association Medical Center and is Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center. His undergraduate degree is from Queens College in New York City (cum laude, Phi Beta Kappa) and his M.D. is from Yale University School of Medicine (cum laude, Alpha Omega Alpha). He did a Residency in Internal Medicine at Yale New-Haven Hospital and a Rheumatology Fellowship at Southwestern Medical School – University of Texas Health Science Center (Dallas) with Morris Ziff, where he spent much of his time in Siberia with Ellen Vitetta. He spent two years as a Research Associate with William Paul in the Laboratory of Immunology, NIAID, NIH during the Vietnam era, where he helped protect Bethesda against an invasion by guinea pigs. In recognition of his heroism, Dr. Finkelman was asked to join the faculty of the Uniformed Services University of the Health Sciences in Bethesda, MD, in 1977. He rose there to the rank of Professor and Director of the Division of Immunology, and left in 1995 to assume his present positions in Cincinnati. Honors include recognition as a “Hero of the Arthritis Foundation,” listing as one of the world’s 100 most-cited immunologists, several visiting professorships, election to the American Society of Clinical Investigation, the American Association of Physicans, and Fellowship in the American Association for the Advancement of Science. He is also a Fellow of the American College of Rheumatology and the American Association for Allergy, Asthma, and Immunology and, since 1975, a member of the American Association of Immunologists. He served as Deputy Editor for the Journal of Immunology from 1992-1997 and has been on the Editorial Boards of Infection and Immunity, International Immunology, and the Journal of Allergy and Clinical Immunology. He has published over 262 peer-reviewed papers plus 63 invited papers and chapters and holds 2 patents. He has chaired a Keystone Symposium, served on Study Sections for NIH and the Arthritis Foundation, NIH’s Transgenic Mouse Committee, a Supervisory Committee for the Immune Tolerance Network, and the Public Affairs, Nomination, Membership, and Program Committees of the American Association of Immunologists, as well as FASEB’s VA Research Funding Committee, which he presently chairs. Dr. Finkelman’s research career has been accurately characterized by more than one reviewer as “diffuse and unfocused:” he uses in vivo mouse models to study B and T cell development, differentiation, and tolerance; membrane immunoglobulin function; cytokine biology; host protection against infectious nematode parasites; asthma; autoimmune disorders, anaphylaxis, and transfusion-related acute lung injury.
|
